Raymond James & Associates’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $963K | Buy |
24,913
+699
| +3% | +$27K | ﹤0.01% | 2698 |
|
|
2024
Q2 | $780K | Buy |
24,214
+467
| +2% | +$15K | ﹤0.01% | 2775 |
|
|
2024
Q1 | $922K | Buy |
+23,747
| New | +$922K | ﹤0.01% | 2635 |
|
|
2019
Q1 | – | Sell |
-13,216
| Closed | -$227K | – | 3498 |
|
|
2018
Q4 | $227K | Sell |
13,216
-13,862
| -51% | -$238K | ﹤0.01% | 3030 |
|
|
2018
Q3 | $399K | Sell |
27,078
-769
| -3% | -$11.3K | ﹤0.01% | 2847 |
|
|
2018
Q2 | $664K | Buy |
27,847
+5,434
| +24% | +$130K | ﹤0.01% | 2491 |
|
|
2018
Q1 | $573K | Buy |
22,413
+1,329
| +6% | +$34K | ﹤0.01% | 2475 |
|
|
2017
Q4 | $389K | Buy |
+21,084
| New | +$389K | ﹤0.01% | 2675 |
|
|
2017
Q2 | – | Sell |
-60,365
| Closed | -$607K | – | 3192 |
|
|
2017
Q1 | $607K | Sell |
60,365
-6,000
| -9% | -$60.3K | ﹤0.01% | 2265 |
|
|
2016
Q4 | $1.03M | Sell |
66,365
-5,550
| -8% | -$86.4K | ﹤0.01% | 1905 |
|
|
2016
Q3 | $1.39M | Buy |
71,915
+3,220
| +5% | +$62K | ﹤0.01% | 1679 |
|
|
2016
Q2 | $814K | Buy |
68,695
+27,520
| +67% | +$326K | ﹤0.01% | 1845 |
|
|
2016
Q1 | $747K | Buy |
+41,175
| New | +$747K | ﹤0.01% | 1821 |
|